Racial disparity and regional variance in healthcare utilization among patients with lung cancer in US hospitals during 2016–2019

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries Cancer J Clin 71 209-49

[2] Ferlay J(2022)National utilization, survival, and costs analysis of Treatment Options for Stage I Non-Small Cell Lung Cancer: a SEER-Medicare Database Analysis Acad Radiol 29 173-S180

[3] Siegel RL(2021)The impact of social determinants of health on management of stage I non-small cell lung cancer Am J Surg Published online Oct 25 e120-9

[4] Mukherjee K(2020)Cost and utilization of Lung Cancer End-of-Life Care among racial-ethnic minority groups in the United States Oncologist 13 1083-93

[5] Davisson N(2018)Racial-ethnic disparities in end-of-Life Care Quality among Lung Cancer Patients: a SEER-Medicare–Based Study J Thorac Oncol 51 15-22

[6] Malik S(2017)Improving cancer patient emergency room utilization: a New Jersey state assessment Cancer Epidemiol 7 227-12

[7] Duszak R(2016)Integrating palliative care in oncologic emergency departments: Challenges and opportunities World J Clin Oncol 29 1304-76

[8] Kokabi N(2020)Medical Care costs Associated with Cancer Survivorship in the United States Cancer Epidemiol Biomarkers Prev 25 69-32

[9] Namburi N(2022)Patterns of Medical Care cost by service type for patients with recurrent and De Novo Advanced Cancer Value in Health 109 225-45

[10] Timsina L(2020)The Effect of Socioeconomic Status on Treatment and Mortality in Non-Small Cell Lung Cancer Patients Ann Thorac Surg 12 437-90

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries Cancer J Clin 71 209-49

[2] Ferlay J(2022)National utilization, survival, and costs analysis of Treatment Options for Stage I Non-Small Cell Lung Cancer: a SEER-Medicare Database Analysis Acad Radiol 29 173-S180

[3] Siegel RL(2021)The impact of social determinants of health on management of stage I non-small cell lung cancer Am J Surg Published online Oct 25 e120-9

[4] Mukherjee K(2020)Cost and utilization of Lung Cancer End-of-Life Care among racial-ethnic minority groups in the United States Oncologist 13 1083-93

[5] Davisson N(2018)Racial-ethnic disparities in end-of-Life Care Quality among Lung Cancer Patients: a SEER-Medicare–Based Study J Thorac Oncol 51 15-22

[6] Malik S(2017)Improving cancer patient emergency room utilization: a New Jersey state assessment Cancer Epidemiol 7 227-12

[7] Duszak R(2016)Integrating palliative care in oncologic emergency departments: Challenges and opportunities World J Clin Oncol 29 1304-76

[8] Kokabi N(2020)Medical Care costs Associated with Cancer Survivorship in the United States Cancer Epidemiol Biomarkers Prev 25 69-32

[9] Namburi N(2022)Patterns of Medical Care cost by service type for patients with recurrent and De Novo Advanced Cancer Value in Health 109 225-45

[10] Timsina L(2020)The Effect of Socioeconomic Status on Treatment and Mortality in Non-Small Cell Lung Cancer Patients Ann Thorac Surg 12 437-90